BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

CeraPedics, Inc. 

11025 Dover Street
Suite 1600
Westminster  Colorado  80021  U.S.A.
Phone: 303-974-6275 Fax: 303-974-6285


SEARCH JOBS




Industry
Medical Device






 Company News
CeraPedics, Inc. Files Premarket Approval Application With FDA For i-FACTOR™ Peptide Enhanced Bone Graft 9/4/2014 11:16:22 AM
CeraPedics, Inc. Closes A $9 Million Term Loan With GE Capital 5/13/2014 7:20:17 AM
GE Believes In CeraPedics, Inc. And Its i-FACTOR Bone Graft 4/21/2014 10:03:31 AM
CeraPedics, Inc. Announces Positive Results From IDE Clinical Trial 3/12/2014 10:26:54 AM
CeraPedics, Inc. To Present Preliminary Outcomes Data From i-FACTOR™ Bone Graft Study At Canaccord Genuity Musculoskeletal Conference 3/5/2014 6:53:01 AM
CeraPedics, Inc. Appoints Glen A. Kashuba as Chief Executive Officer and Jeffrey G. Marx, Ph.D., as President and Chief Operating Officer 5/16/2013 11:07:12 AM
CeraPedics, Inc. Adds New Board Member 3/12/2013 6:25:08 AM
CeraPedics, Inc. Secures $19 Million Series C Financing 12/12/2012 7:07:31 AM
Infuse EU Competitor, CeraPedics, Inc., Working Toward U.S. Clearance for Bone Growth Putty 2/23/2012 8:17:04 AM
CeraPedics, Inc.: Prospective, Randomized, Controlled Trial Demonstrates 98% Fusion Rate at 6-Months and 12-Months with i-FACTOR(TM) Biologic Bone Graft and Superiority versus Autograft in Single- and Multi-Level PLIF Spine Surgery 4/12/2011 9:14:27 AM
12